SPY425.10+2.50 0.59%
DIA341.98+3.20 0.94%
IXIC14,369.71+97.98 0.69%

BRIEF-IMV’S Lead Immunotherapy To Be Investigated In Breast Cancer

05/10/2021 07:59
BRIEF-IMV’S Lead Immunotherapy To Be Investigated In Breast Cancer

- IMV Inc IMV.TO:

  • IMV’S LEAD IMMUNOTHERAPY TO BE INVESTIGATED IN BREAST CANCER

  • IMV INC - STUDY WILL EVALUATE MAVEROPEPIMUT-S WITH AN AROMATASE INHIBITOR, WITH/WITHOUT RADIOTHERAPY OR CYCLOPHOSPHAMIDE PRIOR TO SURGERY

  • IMV - INVESTIGATOR-INITIATED CLINICAL STUDY WILL BE CONDUCTED AT PROVIDENCE CANCER INSTITUTE IN PORTLAND, OREGON & EXPECTED TO BEGIN DURING SUMMER 2021

Source text for Eikon: ID:nBw1V9RrLa

Further company coverage: IMV.TO


(([email protected];))